Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
European Journal of Medicinal Chemistry
|
February 5, 2025
Design and synthesis of novel sulfur-substituted triptolide with the ability to induce autophagy through inhibition of SRSF1 expression
Xinyi Chen, Jichen Guan, Yuzhi Lin, et al.
Molecules (Basel, Switzerland)
|
June 15, 2019
Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents
Hui Wen, Yuke Liu, Shufang Wang, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 14, 2019
Chaperone-mediated autophagy degradation of IGF-1Rβ induced by NVP-AUY922 in pancreatic cancer
Nina Xue, Fangfang Lai, Tingting Du, et al.
European Journal of Medicinal Chemistry
|
March 19, 2026
Novel nitric oxide-releasing triptolidenol derivatives suppress gastric cancer by targeting the folate one-carbon metabolism pathway and inducing ROS accumulation
Yulu Tian, Jichen Guan, Haowen Luo, et al.
BMJ Open Diabetes Research & Care
|
August 26, 2021
Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults
Junfeng Zhang, Qiaoyan Xu, Fangfang Lai, et al.
European Journal of Medicinal Chemistry
|
February 7, 2020
Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies
Yingda Zang, Fangfang Lai, Junmin Fu, et al.
Bioorganic & Medicinal Chemistry
|
August 24, 2025
Discovery of bromobenzyl phenyl ether derivative YPD-29B: a novel pre-clinical compound targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction
Yang Yang, Meiqin Xu, Ke Wang, et al.
Oncotargets and Therapy
|
July 10, 2018
CAT<sub>3</sub>, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O<sup>6</sup>-methylguanine DNA methyltransferase expression
Ming Ji, Liyuan Wang, Ju Chen, et al.
Free Radical Biology & Medicine
|
April 8, 2014
Involvement of Na/K-ATPase in hydrogen peroxide-induced activation of the Src/ERK pathway in LLC-PK1 cells
Yu Wang, Qiqi Ye, Changxuan Liu, et al.
Acta Pharmaceutica Sinica. B
|
July 31, 2023
Erratum: Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" [Acta Pharmaceutica Sinica B 12 (2022) 2845-2858]
Fangfang Lai, Ming Ji, Lei Huang, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
European Journal of Medicinal Chemistry
|
February 5, 2025
Design and synthesis of novel sulfur-substituted triptolide with the ability to induce autophagy through inhibition of SRSF1 expression
Xinyi Chen, Jichen Guan, Yuzhi Lin, et al.
Molecules (Basel, Switzerland)
|
June 15, 2019
Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents
Hui Wen, Yuke Liu, Shufang Wang, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 14, 2019
Chaperone-mediated autophagy degradation of IGF-1Rβ induced by NVP-AUY922 in pancreatic cancer
Nina Xue, Fangfang Lai, Tingting Du, et al.
European Journal of Medicinal Chemistry
|
March 19, 2026
Novel nitric oxide-releasing triptolidenol derivatives suppress gastric cancer by targeting the folate one-carbon metabolism pathway and inducing ROS accumulation
Yulu Tian, Jichen Guan, Haowen Luo, et al.
BMJ Open Diabetes Research & Care
|
August 26, 2021
Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults
Junfeng Zhang, Qiaoyan Xu, Fangfang Lai, et al.
European Journal of Medicinal Chemistry
|
February 7, 2020
Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies
Yingda Zang, Fangfang Lai, Junmin Fu, et al.
Bioorganic & Medicinal Chemistry
|
August 24, 2025
Discovery of bromobenzyl phenyl ether derivative YPD-29B: a novel pre-clinical compound targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction
Yang Yang, Meiqin Xu, Ke Wang, et al.
Oncotargets and Therapy
|
July 10, 2018
CAT<sub>3</sub>, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O<sup>6</sup>-methylguanine DNA methyltransferase expression
Ming Ji, Liyuan Wang, Ju Chen, et al.
Free Radical Biology & Medicine
|
April 8, 2014
Involvement of Na/K-ATPase in hydrogen peroxide-induced activation of the Src/ERK pathway in LLC-PK1 cells
Yu Wang, Qiqi Ye, Changxuan Liu, et al.
Acta Pharmaceutica Sinica. B
|
July 31, 2023
Erratum: Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" [Acta Pharmaceutica Sinica B 12 (2022) 2845-2858]
Fangfang Lai, Ming Ji, Lei Huang, et al.
Page
of 7